- Nachrichtendetail
-
18.06.2024 08:06:49 - dpa-AFX: *ASTRAZENECA : PHASE III TRIAL OF TRUQAP PLUS CHEMOTHERAPY IN ADVANCED BREAST CANCER FAILS TO MEET MAIN GOAL
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ASTRAZENECA PLC DL-,25 | 886455 | Xetra | 142,800 | 02.07.24 16:31:48 | -2,350 | -1,62% | 142,550 | 142,750 | 144,500 | 145,150 |
|
ROCHE HLDG AG GEN. | 855167 | Hamburg | 0,000 | 02.07.24 16:50:44 | ±0,000 | ±0,00% | 0,000 | 0,000 | 0,000 | 245,550 |
